AXIS Capital Limited
Rating
Updated: Aug 27, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
AXIS Capital Holdings Ltd. engages in the provision of various insurance and reinsurance products and services. It operates through the Insurance and Reinsurance segments. The Insurance segment offers...
Latest News
3 days ago · defenseworld.net
Corient Private Wealth LP Sells 15,155 Shares of Axis Capital Holdings Limited $AXSCorient Private Wealth LP trimmed its position in shares of Axis Capital Holdings Limited (NYSE: AXS) by 18.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 65,879 shares of the insurance provider's stock after selling 15,155 shares during the quarter. Corient Private
4 days ago · globenewswire.com
Axis Capital Declares Quarterly DividendsPEMBROKE, Bermuda, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital" or the “Company”) (NYSE: AXS) today announced that its Board of Directors has declared a quarterly dividend of $0.44 per common share payable on October 15, 2026 to shareholders of record at the close of business on September 30, 2026.
11 days ago · businesswire.com
AXS Joins AVA Presents to Power the Next Chapter of Colorado Springs' Historic CityAudLOS ANGELES & COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--AXS Joins AVA Presents to Power the Next Chapter of Colorado Springs' Historic CityAud.
20 days ago · zacks.com
Axsome Begins Phase III Study on AXS-05 for Smoking CessationAXSM begins dosing in the phase III SUMMIT study investigating AXS-05 for treating smoking cessation in adults.
21 days ago · globenewswire.com
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking CessationNEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been dosed in the SUMMIT Phase 3 trial of AXS-05 for smoking cessation. SUMMIT (Studying NMDA and Sigma-1 in Smoking Cessation Treatment) is a Phase 3 randomized, double-blind, active- and placebo-controlled, multicenter trial to assess the efficacy and safety of AXS-05 as a smoking cessation treatment in adults.
25 days ago · zacks.com
Why Is Axis Capital (AXS) Down 5.6% Since Last Earnings Report?Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
1 month ago · seekingalpha.com
AXS PFD E Offers Competitive Yield Versus Other Insurance CompaniesAXIS Capital Holdings Limited offers diversified specialty insurance and reinsurance, with strong A+ credit ratings and a BBB-rated preferred stock AXS.PR.E. AXS reported 15% YOY growth in both premiums written and diluted book value, with a solid 93.1% combined ratio, though reinsurance premiums declined 25%. The fixed-rate, non-cumulative Series E preferred AXS.PR.E offers QDI-eligible dividends and BBB credit quality, appealing for income-focused investors seeking stability.
1 month ago · defenseworld.net
Bank of America Corp DE Reduces Stock Position in Axis Capital Holdings Limited $AXSBank of America Corp DE lessened its stake in Axis Capital Holdings Limited (NYSE: AXS) by 7.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 473,337 shares of the insurance provider's stock after selling 35,912 shares during the quarter. Bank
1 month ago · zacks.com
AXS Lags Industry, Trades at a Discount: Here's How to Play the StockAXIS Capital's specialty focus, premium growth and capital returns support growth, while catastrophe losses and competition pressure on underwriting margins.
2 months ago · businesswire.com
AXS Named Exclusive Primary and Secondary Ticketing Partner for the Wrangler National Finals RodeoLOS ANGELES & LAS VEGAS--(BUSINESS WIRE)--AXS Named Exclusive Primary and Secondary Ticketing Partner for the Wrangler National Finals Rodeo.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove AXS